Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells†
Open Access
- 13 October 2014
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 46 (6), e103-e112
- https://doi.org/10.1093/ejcts/ezu359
Abstract
The aim of the present study was to characterize the biological properties and in vivo tumourigenic potential of mesenchymal cells (MCs) obtained from non-small-cell lung cancer (NSCLC) samples.NSCLC samples (53 adenocarcinomas and 24 squamous-cell carcinomas) surgically removed from 46 males and 31 females were processed to identify mesenchymal cells from human lung cancer (hLc-MCs). hLc-MCs were separated from neoplastic epithelial cells, expanded and extensively characterized in vitro. Subsequently, female BALB/c nude mice were subcutaneously injected with either 10(6) or 2.5 × 10(6) Calu-3 (human adenocarcinoma cell line able to reproducibly induce xenografted tumours) alone or in combination with equal doses of hLc-MCs. Control animals were injected with the two doses of hLc-MCs only.Primary cultures of hLc-MCs were obtained from >80% of NSCLC specimens. The typical MCs immunophenotype was documented by the expression of CD90, CD105, CD73, CD13 and CD44 at fluorescence-activated cell sorting analysis. CD45, CD14, CD34 and epithelial antigens were negative while CD117 (c-kit) and CD133 (prominin) were partially expressed. Interestingly, nuclear transcription factors octamer-binding transcription factor 3/4 and sex determining region Y-box 2 involved in stemness, thyroid transcription factor 1 in bronchoalveolar commitment, and ETS1 in carcinogenesis, were expressed in hLc-MCs isolated from NSCLC. Specific conditioned media and cocultures confirmed the supportive role of hLc-MCs for cancer cells. In vivo experiments showed that at both doses Calu-3 xenografts doubled in size when hLc-MCs were coinjected. Cell tracking in xenografted tumours, by immunofluorescence combined with fluorescence in situ hybridization analysis, documented hX-chromosome-labelled, Calu-3-derived cytokeratin-positive adenocarcinoma structures surrounded by hLc-MCs.Tumour-propagating cells require the inductive interaction of resident mesenchymal cells to foster lung cancer development.This publication has 24 references indexed in Scilit:
- Human Mesenchymal Stem Cells Promote Cancer Motility and Cytokine Secretion in vitroCells Tissues Organs, 2013
- Mesenchymal stem cells in non-small cell lung cancer—Different from others? Insights from comparative molecular and functional analysesLung Cancer, 2013
- Cancer stem cell definitions and terminology: the devil is in the detailsNature Reviews Cancer, 2012
- The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- α-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal AdenocarcinomaPancreas, 2010
- The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer☆☆☆European Journal of Cardio-Thoracic Surgery, 2009
- A Perivascular Niche for Brain Tumor Stem CellsCancer Cell, 2007
- The stem-cell niche as an entity of actionNature, 2006
- Disrupting tumour blood vesselsNature Reviews Cancer, 2005
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004